featured
Serious Adverse Events of Special Interest Following mRNA COVID-19 Vaccination in Randomized Trials in Adults
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Vaccine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults
Vaccine 2022 Sep 22;40(40)5798-5805, J Fraiman, J Erviti, M Jones, S Greenland, P Whelan, RM Kaplan, P DoshiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.